Healthcare provider profile · identity verified

Parul Gupta, M.D.

Internal Medicine · FARGO, ND · NPI 1669483038

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Jantoven	Warfarin Sodium	679	25
Levothyroxine Sodium	Levothyroxine Sodium	658	72
Amlodipine Besylate	Amlodipine Besylate	624	68
Furosemide	Furosemide	612	91
Metoprolol Succinate	Metoprolol Succinate	520	65
Atorvastatin Calcium	Atorvastatin Calcium	458	65
Gabapentin	Gabapentin	456	57
Omeprazole	Omeprazole	414	52
Pantoprazole Sodium	Pantoprazole Sodium	378	51
Duloxetine Hcl	Duloxetine Hcl	313	22
Eliquis	Apixaban	311	43
Sertraline Hcl	Sertraline Hcl	309	41
Potassium Chloride	Potassium Chloride	307	42
Buspirone Hcl	Buspirone Hcl	291	32
Lisinopril	Lisinopril	287	30
Donepezil Hcl	Donepezil Hcl	286	28
Losartan Potassium	Losartan Potassium	269	32
Carvedilol	Carvedilol	260	24
Escitalopram Oxalate	Escitalopram Oxalate	258	26
Warfarin Sodium	Warfarin Sodium	252	21
Citalopram Hbr	Citalopram Hydrobromide	203	23
Trazodone Hcl	Trazodone Hcl	201	38
Tamsulosin Hcl	Tamsulosin Hcl	184	23
Simvastatin	Simvastatin	176	15
Metoprolol Tartrate	Metoprolol Tartrate	165	27
Clopidogrel	Clopidogrel Bisulfate	143	18
Carbidopa-Levodopa	Carbidopa/Levodopa	138	15
Mirtazapine	Mirtazapine	130	24
Venlafaxine Hcl Er	Venlafaxine Hcl	130	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	129	20
Metformin Hcl	Metformin Hcl	125	19
Memantine Hcl	Memantine Hcl	122	14
Famotidine	Famotidine	121	22
Tramadol Hcl	Tramadol Hcl	113	35
Metformin Hcl Er	Metformin Hcl	111	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	110	25
Bumetanide	Bumetanide	108	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	103	18
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	102	18
Finasteride	Finasteride	100	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	96	22
Ropinirole Hcl	Ropinirole Hcl	91	16
Ezetimibe	Ezetimibe	90	suppressed
Levetiracetam	Levetiracetam	90	suppressed
Oxycodone Hcl	Oxycodone Hcl	88	31
Hydrochlorothiazide	Hydrochlorothiazide	87	12
Pravastatin Sodium	Pravastatin Sodium	86	suppressed
Torsemide	Torsemide	84	13
Fluoxetine Hcl	Fluoxetine Hcl	83	12
Divalproex Sodium Er	Divalproex Sodium	81	suppressed
Latanoprost	Latanoprost	79	13
Klor-Con M20	Potassium Chloride	78	suppressed
Bupropion Xl	Bupropion Hcl	75	suppressed
Prednisone	Prednisone	74	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	72	15
Myrbetriq	Mirabegron	72	suppressed
Ondansetron Hcl	Ondansetron Hcl	72	24
Lamotrigine	Lamotrigine	66	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	64	13
Allopurinol	Allopurinol	61	suppressed
Spironolactone	Spironolactone	61	13
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	60	15
Lorazepam	Lorazepam	60	23
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	59	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	59	15
Klor-Con M10	Potassium Chloride	57	suppressed
Baclofen	Baclofen	56	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	53	suppressed
Hydralazine Hcl	Hydralazine Hcl	52	suppressed
Propranolol Hcl	Propranolol Hcl	49	suppressed
Bupropion Hcl Sr	Bupropion Hcl	48	suppressed
Digoxin	Digoxin	48	suppressed
Fluticasone Propionate	Fluticasone Propionate	46	23
Glimepiride	Glimepiride	45	suppressed
Paroxetine Hcl	Paroxetine Hcl	45	suppressed
Topiramate	Topiramate	45	suppressed
Aripiprazole	Aripiprazole	44	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	43	suppressed
Alendronate Sodium	Alendronate Sodium	40	suppressed
Xarelto	Rivaroxaban	39	suppressed
Cephalexin	Cephalexin	37	16
Rytary	Carbidopa/Levodopa	36	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	11
Glipizide	Glipizide	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Jardiance	Empagliflozin	32	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Olanzapine	Olanzapine	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Liothyronine Sodium	Liothyronine Sodium	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Amiodarone Hcl	Amiodarone Hcl	29	suppressed
Clonazepam	Clonazepam	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Timolol Maleate	Timolol Maleate	28	suppressed
Cilostazol	Cilostazol	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Risperidone	Risperidone	27	suppressed
Glipizide Er	Glipizide	26	suppressed
Memantine Hcl Er	Memantine Hcl	26	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	suppressed
Brilinta	Ticagrelor	24	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Sodium Bicarbonate	Sodium Bicarbonate	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	17
Diltiazem 24hr Er	Diltiazem Hcl	23	suppressed
Methimazole	Methimazole	23	suppressed
Sucralfate	Sucralfate	23	suppressed
Midodrine Hcl	Midodrine Hcl	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	suppressed
Ondansetron Odt	Ondansetron	22	16
Cevimeline Hcl	Cevimeline Hcl	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	19	16
Febuxostat	Febuxostat	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	16
Atenolol	Atenolol	18	suppressed
Methenamine Hippurate	Methenamine Hippurate	18	suppressed
Ozempic	Semaglutide	17	suppressed
Rexulti	Brexpiprazole	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Albuterol Sulfate	Albuterol Sulfate	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Nucynta	Tapentadol Hcl	16	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Budesonide	Budesonide	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Lubiprostone	Lubiprostone	15	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	15	suppressed
Trospium Chloride	Trospium Chloride	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	12
Insulin Aspart Flexpen	Insulin Aspart	14	suppressed
Nitroglycerin	Nitroglycerin	14	13
Enalapril Maleate	Enalapril Maleate	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Mesalamine	Mesalamine	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Calcitriol	Calcitriol	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Gemtesa	Vibegron	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Linzess	Linaclotide	12	suppressed
Metolazone	Metolazone	12	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	12	11
Alprazolam	Alprazolam	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error